Fwl Investment Management »

Moleculin Biotech shares owned by Fwl Investment Management

Quarter-by-quarter ownership of Moleculin Biotech (MBRX) shares owned by Fwl Investment Management from 13F filings

Historical chart of Fwl Investment Management investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by Fwl Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by Fwl Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6k 278 5.91

More positions owned by Fwl Investment Management

Alphabet Inc Cap Stk Cl C Stock (GOOG)
Microsoft Corp Stock (MSFT)
Ishares U.s. Medical Devices Etf Etf (IHI)
Vaneck Gold Miners Etf Etf (GDX)
Cheniere Energy Stock (LNG)
Alerian Mlp Etf Etf (AMLP)
Spdr Gold Shares Etf (GLD)
Cyberark Software Stock (CYBR)
Oracle Corp Stock (ORCL)
Lockheed Martin Corp Stock (LMT)
Nvidia Corporation Stock (NVDA)
Icici Bank Adr (IBN)
Williams Cos Stock (WMB)
Apple Stock (AAPL)
Datadog Inc Cl A Stock (DDOG)

View all positions for Fwl Investment Management

Top funds holding Moleculin Biotech

Armistice Capital
LPL Financial
Vanguard Group
Geode Capital Management
BlackRock
Renaissance Technologies
Branch Banking & Trust Company
UBS Group
Tower Research Capital
Atticus Wealth Management
Newbridge Financial Services Group
Morgan Stanley
SBI Securities
Bogart Wealth
Bank of America Corporation

View all funds holding Moleculin Biotech